Almacgroup.com

Almac Group. Providing a range of contract pharmaceutical development and manufacturing services globally.

What’s new on Almacgroup.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Almacgroup.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Almac Group

Subscribe to related news

Queen's University Research Fellowship Scheme 2014 - 2015
via naveenbioinformatics

Queen's University Research Fellowship Scheme Our new Research Fellowship Scheme has been established to attract outstanding and ambitious researchers from across the globe to join Queen's University. Our successful Fellows will be able to access exceptional...
AMRI to Acquire Oso Biopharmaceuticals Manufacturing
via en.prnasia

- Significantly Expands Contract Manufacturing Capabilities to Include Commercial Scale Sterile Injectables - ALBANY, New York, June 3, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire...
Aptuit Names Jonathan Goldman As CEO
via altnews

GREENWICH, Conn., Dec. 2, 2013 /PRNewswire/ -- Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company's senior management leadership team. (Logo: http...
Vetter announces completion of its Schuetzenstrasse multi-functional building for Development Service and state-of-the-a...
via pressreleaserocket

2015 Developments reflect another positive year of growth for the pharmaceutical service provider Ravensburg, Germany (PRWEB) January 31, 2016 Vetter, a leading contract development and manufacturing organization (CDMO) committed to providing customers...
Chronic Obstructive Pulmonary Disease Market is Predicted to have a Significant Growth in Pharmaceuticals & Healthca...
via northcarolinaheadlines

The current “Chronic Obstructive Pulmonary Disease (COPD)” pipeline consists of 212 active products in development. Initial analysis revealed a small presence of first-in-class products, constituting 16.5% of the pipeline. In comparison to other indications...

Almacgroup.com popular pages

Partnering to Advance Human Health - Almac

Partnering to Advance Human Health. Providing a range of contract pharmaceutical development and manufacturing services globally.
Biostatistical Services - Almac

World-Class Biostatistical Services for patient randomization methodologies, IXRS implementation and eCOA. Click here to learn more about these services.

Custom Peptide Synthesis for Research Use - Almac

Custom peptide synthesis for research use - Specialising in High Quality Peptides. Click here to read more.